Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.877,39
1,57%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 89bio Inc (ETNB) 89bio Inc (ETNB) Notizie

89bio Inc

ETNB
9,22
0,36 (4,06%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/3/202423:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..
01/3/202423:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:10EDGAR2Form 8-K - Current report
24/2/202402:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:43EDGAR2Form 8-K - Current report
08/12/202312:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202322:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202322:02EDGAR2Form 8-K - Current report
04/12/202313:01EDGAR2Form 8-K - Current report
27/11/202314:01EDGAR2Form 8-K - Current report
14/11/202322:30EDGAR2Form 8-K - Current report
09/11/202321:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202302:41EDGAR2Form 8-K - Current report
21/9/202315:07DJN89bio Gets FDA Breakthrough Designation for Pegozafermin in..
12/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:27EDGAR2Form 8-K - Current report
09/8/202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:12EDGAR2Form 8-K - Current report
06/7/202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 9,19 Min: 8,90 Max: 9,35
Chiusura: 8,86

La tua Cronologia

NASDAQ
ETNB
89bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network